Compare · CAH vs HSIC
CAH vs HSIC
Side-by-side comparison of Cardinal Health Inc. (CAH) and Henry Schein Inc. (HSIC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. CAH focuses on Other Pharmaceuticals, while HSIC focuses on Medical Specialities.
- CAH is the larger of the two at $63.06B, about 6.8x HSIC ($9.23B).
- CAH has been more active in the news (17 items in the past 4 weeks vs 9 for HSIC).
- Both have 25 recent analyst ratings on file.
- Company
- Cardinal Health Inc.
- Henry Schein Inc.
- Price
- -
- -
- Market cap
- $63.06B
- $9.23B
- 1M return
- -
- -2.89%
- 1Y return
- -
- +12.10%
- Industry
- Other Pharmaceuticals
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 1995
- News (4w)
- 17
- 9
- Recent ratings
- 25
- 25
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Henry Schein Inc.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Latest CAH
- Director Hall Patricia Hemingway was granted 1,204 shares, increasing direct ownership by 4% to 29,849 units (SEC Form 4)
- Director Johri Akhil was granted 1 shares, increasing direct ownership by 0.00% to 22,869 units (SEC Form 4)
- Director Killefer Nancy was granted 755 shares, increasing direct ownership by 3% to 28,379 units (SEC Form 4)
- Director Mundkur Christine was granted 755 shares, increasing direct ownership by 10% to 8,291 units (SEC Form 4)
- Director Musslewhite Robert W was granted 755 shares, increasing direct ownership by 36% to 2,871 units (SEC Form 4)
- Director Ramakrishna Sudhakar was granted 755 shares, increasing direct ownership by 36% to 2,871 units (SEC Form 4)
- Director Edison Sheri H. was granted 755 shares, increasing direct ownership by 5% to 15,603 units (SEC Form 4)
- New insider Zielinski Anita A claimed ownership of 5,715 shares (SEC Form 3)
- Director Evans David C was granted 755 shares, increasing direct ownership by 5% to 16,128 units (SEC Form 4)
- Director Brennan Michelle was granted 755 shares, increasing direct ownership by 9% to 8,841 units (SEC Form 4)
Latest HSIC
- Henry Schein Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Henry Schein Updates Presentation of Non-GAAP Financial Measures
- Amendment: SEC Form SCHEDULE 13G/A filed by Henry Schein Inc.
- CareQuest and Henry Schein Launch the BRIDGE Health Network to Advance Dental-Medical Integration
- New insider Caprais Emmanuel claimed no ownership of stock in the company (SEC Form 3)
- Henry Schein to Participate in Upcoming Investor Conferences in November and December
- SEC Form 10-Q filed by Henry Schein Inc.
- Henry Schein Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
- Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET